I could be wrong, but it looks like you accessed iPPS through the Special Access Scheme, so you're OA is not likely to fall within the scope of what PAR intend to treat. PAR have an extensive list of inclusion and exclusion criteria for the clinical trials and if you met this criteria then I suspect PAR wouldn't have authorised its use.
Dr Sharma doesn't appear to be involved in these clinical trials, but can obviously make a request to PAR to release iPPS through the Special Access Scheme. Did your MRI show bone marrow lesion's? Do you care to share a before and after image?
Ann: Paradigm Reports Australian Patent Acceptance, page-32
-
- There are more pages in this discussion • 33 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
26.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $92.81M | |||
| Open | High | Low | Value | Volume |
| 27.0¢ | 29.0¢ | 25.5¢ | $430.3K | 1.585M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5500 | 26.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.5¢ | 36162 | 3 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| PAR (ASX) Chart |